Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accrual, adequacy, AdProTech, aforementioned, andSalmonella, annum, APB, blended, budgeted, Cape, categorized, CFO, cholerea, classification, Cod, collateralized, contingent, Cooke, COSO, deposit, deteriorate, disbursement, disposition, distance, doubtful, drawn, easily, encouraged, equal, EquiServe, fermentation, Fifty, holding, Importantly, inadvertent, inCirculation, Inflazyme, infrastructure, inInternal, invoiced, Keilani, LLP, loan, Mexican, Mexico, mid, monthly, Outline, owed, Pacific, paper, pertain, professional, Promissory, pronouncement, ramp, reevaluate, release, reschedule, reset, resetting, revised, rPA, run, Sanofi, stop, supplier, Taha, Timothy, translated, translation, Treadway, undistributed, unrealized, unvested, upfront, USA, voluntarily
Removed:
abandoned, additionally, approximated, auditing, breast, cellular, composed, conservative, CTL, cytotoxic, discounting, distinguished, divesting, efficiently, Enterotoxigenic, Esperion, estimating, fight, formation, Henson, indefinite, induce, induced, influenza, Jewish, Karolinska, Langer, Libby, Lyme, Mak, medicine, melanoma, Michigan, minute, Nomura, Ontario, ovarian, PaineWebber, peter, Pharma, potent, producing, prostate, redeem, redeemed, representation, resolution, reviewed, Robert, safely, School, settlement, SMIR, split, Stanford, STTR, sublessee, submit, Tak, thousandth, upside, vivo, ward, Wigzell, write
Filing tables
Filing exhibits
Related press release
CLDX similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
The undersigned officers of AVANT Immunotherapeutics, Inc. (the "Company") hereby certify to our knowledge that the Company's annual report on Form 10-K to which this certification is attached (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 16, 2005 | By: | /s/ UNA S. RYAN Name: Una S. Ryan, Ph.D. Title: President and Chief Executive Officer | |
Date: March 16, 2005 | By: | /s/ AVERY W. CATLIN Name: Avery W. Catlin Title: Senior Vice President and Chief Financial Officer |